DXR insider filings
DAXOR CORP — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2026-09-01. Screen DXR transaction legs live →
Insider transaction summary — last 90 days
2026-07-10 to 2026-10-08, from the filings listed below: 1 insider filing (Forms 3/4/5). Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 1.
By insider — same window
Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Insider | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|
| Jefferies John — Chief Medical Officer | 1 | — | — | 1 |
Recent insider filings — DAXOR CORP
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-01 | 4 | Jefferies John — Chief Medical Officer | Grant/award (A): 2,451 @ $0 | EDGAR |
| 2026-06-25 | 4 | DesRosiers Caleb — Director | Grant/award (A): 2,500 (derivative) @ $0 | EDGAR |
| 2026-06-25 | 4 | Goudie Joy S. — Director | Grant/award (A): 2,500 (derivative) @ $0 | EDGAR |
| 2026-06-25 | 4 | Cremisi Henry D. — Director | Grant/award (A): 2,500 (derivative) @ $0 | EDGAR |
| 2026-06-25 | 4 | Feldschuh Jonathan Adam — Chief Scientific Officer, Director | Grant/award (A): 25,000 @ $0 | EDGAR |
| 2026-06-25 | 4 | Feuer Edward — Director | Grant/award (A): 2,500 (derivative) @ $0 | EDGAR |
| 2026-06-25 | 4 | Feldschuh Michael Richard — Chief Executive Officer, Director | Grant/award (A): 30,000 @ $0 | EDGAR |
| 2026-06-25 | 4 | Michel Robert J — Chief Financial Officer | Grant/award (A): 12,000 @ $0 | EDGAR |
| 2026-04-10 | 4 | Feldschuh Michael Richard — Chief Executive Officer, Director | Purchase (P): 1,000 @ $9.07 | EDGAR |
| 2026-03-31 | 4 | Michel Robert J — Chief Financial Officer | Purchase (P): 1,000 @ $9.90 | EDGAR |
| 2026-03-24 | 4 | Jefferies John — Chief Medical Officer | Purchase (P): 3,656 @ $0 · Purchase (P): 2,285 @ $0 | EDGAR |
| 2025-12-11 | 4 | Feldschuh Jonathan Adam — Chief Scientific Officer, Director | Purchase (P): 18,000 @ $0 | EDGAR |
| 2025-12-11 | 4 | Michel Robert J — Chief Financial Officer | Purchase (P): 3,000 @ $0 | EDGAR |
| 2025-11-14 | 4 | Jefferies John — Chief Medical Officer | Purchase (P): 2,344 @ $0 | EDGAR |
| 2025-06-26 | 4 | DesRosiers Caleb — Director | Grant/award (A): 2,500 (derivative) @ $0 | EDGAR |
| 2025-06-26 | 4 | Goudie Joy S. — Director | Grant/award (A): 2,500 (derivative) @ $0 | EDGAR |
| 2025-06-26 | 4 | Cremisi Henry D. — Director | Grant/award (A): 2,500 (derivative) @ $0 | EDGAR |
| 2025-06-26 | 4 | Feuer Edward — Director | Grant/award (A): 2,500 (derivative) @ $0 | EDGAR |
| 2025-04-07 | 4 | Feldschuh Michael Richard — Chief Executive Officer, Director | Purchase (P): 2,063 @ $7.89 | EDGAR |
| 2025-03-27 | 4 | Feldschuh Michael Richard — Chief Executive Office, Director | Purchase (P): 1,000 @ $8.13 | EDGAR |
| 2025-03-20 | 4 | Feldschuh Michael Richard — Chief Executive Officer, Director | Purchase (P): 647 @ $8.15 | EDGAR |
| 2025-03-20 | 4/A | Feldschuh Michael Richard — Chief Executive Officer, Director | Purchase (P): 1,492 @ $7.72 | EDGAR |
| 2025-03-11 | 4 | Feldschuh Michael Richard — Chief Executive Officer, Director | Purchase (P): 3,360 @ $7.68 | EDGAR |
| 2025-03-11 | 4 | Michel Robert J — Chief Financial Officer | Purchase (P): 1,000 @ $8 | EDGAR |
| 2024-12-10 | 4 | Feldschuh Jonathan Adam — Chief Scientific Officer, Director | Purchase (P): 32,000 @ $0 | EDGAR |
| 2024-12-10 | 4 | Feldschuh Michael Richard — Chief Executive Officer, Director | Purchase (P): 45,000 @ $0 | EDGAR |
| 2024-12-10 | 4 | Michel Robert J — Chief Financial Officer | Purchase (P): 4,750 @ $0 | EDGAR |
| 2024-07-17 | 4 | DesRosiers Caleb — Director | Grant/award (A): 2,500 (derivative) @ $0 | EDGAR |
| 2024-07-17 | 4 | Goudie Joy S. — Director | Grant/award (A): 2,500 (derivative) @ $0 | EDGAR |
| 2024-07-17 | 4 | Cremisi Henry D. — Director | Grant/award (A): 2,500 (derivative) @ $0 | EDGAR |
| 2024-07-17 | 4 | Feuer Edward — Director | Grant/award (A): 2,500 (derivative) @ $0 | EDGAR |
| 2024-03-27 | 4 | Michel Robert J — Chief Financial Officer | Purchase (P): 750 @ $8.70 | EDGAR |
| 2024-03-06 | 4 | Feuer Edward — Director | Purchase (P): 1,000 @ $7.21 | EDGAR |
| 2023-12-06 | 4 | Michel Robert J — Chief Financial Officer | Purchase (P): 120 @ $7.75 | EDGAR |
| 2023-12-01 | 4 | Feldschuh Michael Richard — Chief Executive Officer, Director | Purchase (P): 800 @ $7.80 | EDGAR |
| 2023-12-01 | 4 | Michel Robert J — Chief Financial Officer | Purchase (P): 180 @ $7.75 | EDGAR |
| 2023-11-27 | 4 | Michel Robert J — Chief Financial Officer | Purchase (P): 500 @ $7.94 | EDGAR |
| 2023-11-24 | 4 | Feldschuh Michael Richard — CHIEF EXECUTIVE OFFICER, Director | Grant/award (A): 84 @ $7.65 | EDGAR |
| 2023-11-13 | 4 | Feldschuh Michael Richard — CHIEF EXECUTIVE OFFICER, Director | Purchase (P): 401 @ $7.85 · Purchase (P): 1,001 @ $7.83 | EDGAR |
| 2023-11-02 | 4 | Michel Robert J — Chief Financial Officer | Grant/award (A): 2,000 @ $0 · Grant/award (A): 5,000 (derivative) @ $0 | EDGAR |
| 2023-10-16 | 4 | Michel Robert J — Chief Financial Officer | Purchase (P): 500 @ $9.02 | EDGAR |
| 2023-09-20 | 4 | Estate of Joseph Feldschuh — 10% owner | Gift (G): 25,000 @ $0 | EDGAR |
| 2023-07-13 | 4 | DesRosiers Caleb — Director | Grant/award (A): 2,500 (derivative) @ $0 | EDGAR |
| 2023-07-13 | 4 | Goudie Joy S. — Director | Grant/award (A): 2,500 (derivative) @ $0 | EDGAR |
| 2023-07-13 | 4 | Cremisi Henry D. — Director | Grant/award (A): 2,500 (derivative) @ $0 | EDGAR |
| 2023-07-13 | 4 | Feldschuh Jonathan Adam — Chief Scientific Officer, Director | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2023-07-13 | 4 | Feuer Edward — Director | Grant/award (A): 2,500 (derivative) @ $0 | EDGAR |
| 2023-07-13 | 4 | Feldschuh Michael Richard — Chairman, President & CEO, Director | Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
| 2023-07-13 | 4 | Michel Robert J — Chief Financial Officer | Grant/award (A): 14,000 (derivative) @ $0 | EDGAR |
| 2023-07-13 | 4 | LOMBARD JAMES A — Director | Grant/award (A): 2,500 (derivative) @ $0 | EDGAR |
Recent 8-K events — DAXOR CORP
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-06-24 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2026-01-26 | 8-K | 1.01 — Entry into a Material Definitive Agreement 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-01-23 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-08-07 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-07-01 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2024-07-18 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2024-06-05 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing | EDGAR |
| 2024-03-25 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2024-01-02 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2023-11-28 | 8-K | 8.01 — Other Events | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=DXR returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →